| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/16/2004 | WO2004081198A3 Methods for modulating angiogenesis with apelin compositions |
| 12/16/2004 | WO2004065417A3 Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture |
| 12/16/2004 | WO2004062602A3 Compositions and methods for targeted biological delivery of molecular carriers |
| 12/16/2004 | WO2004032838A3 Methods for treating cancer by inhibiting wnt signaling |
| 12/16/2004 | WO2004022697A3 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 12/16/2004 | WO2004010951A3 Method of treating tumors |
| 12/16/2004 | WO2003104434A3 A method to amplify variable sequences without imposing primer sequences |
| 12/16/2004 | WO2003090514A8 Adipocyte complement related protein zacrp14 |
| 12/16/2004 | WO2003057833A3 Mutant chromophores/fluorophores and methods for making and using the same |
| 12/16/2004 | WO2003000176A8 Conjugates of reduced antibodies and biomolecules |
| 12/16/2004 | US20040254363 Genes and snps associated with eating disorders |
| 12/16/2004 | US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 12/16/2004 | US20040254361 Gene encoding protein from merozoite of Babesia caballi, recombinant protein obtained with said gene and use thereof |
| 12/16/2004 | US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders |
| 12/16/2004 | US20040254349 Mycobacterial antigens expressed under low oxygen tension |
| 12/16/2004 | US20040254348 Opiate receptor therapeutic protein/peptides for use in pain relief and management |
| 12/16/2004 | US20040254346 Human survivin interacting protein 1 (sip-1) |
| 12/16/2004 | US20040254144 Use of inhibitors of heparin-binding epidermal growth factor or inhibitors of its receptors for the preparation of drugs useful for treating myeloma |
| 12/16/2004 | US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation |
| 12/16/2004 | US20040254111 Regulator of apoptosis and cell proliferation |
| 12/16/2004 | US20040254108 Preparation and application of anti-tumor bifunctional fusion proteins |
| 12/16/2004 | US20040253711 Mycobacterial genes down-regulated during latency |
| 12/16/2004 | US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases |
| 12/16/2004 | US20040253698 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/16/2004 | US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders |
| 12/16/2004 | US20040253682 Immunloglobulin prostaglandin inhibitor for use in the treatment and prevention of arthritic and inflammatory bowel disorders |
| 12/16/2004 | US20040253681 Mitogenic oxygenase regulators |
| 12/16/2004 | US20040253674 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 12/16/2004 | US20040253673 Recombinant botulinum toxins with a soluble C-terminal portion |
| 12/16/2004 | US20040253667 Expression vector comprising nuclelotide sequences coding membrane protein for use in identifying modulator for treatment of cell proliferative, nervous system and inflammatory diseases |
| 12/16/2004 | US20040253666 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/16/2004 | US20040253655 Immunoassay for use in detection high blood pressure; immunodiagnostics |
| 12/16/2004 | US20040253653 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents; immunotherapy |
| 12/16/2004 | US20040253645 Monoclonal antibody with enhanced species preference; immunotherapy |
| 12/16/2004 | US20040253643 Using ratio of neurofibrillary tangle to amyloid beta protein in cerebrospinal fluid as diagnostic indicator of nervous system disorders; immunodiagnostics |
| 12/16/2004 | US20040253638 Immunoglobulins devoid of light chains |
| 12/16/2004 | US20040253611 Immunologically active proteins from borrelia burgdorferi |
| 12/16/2004 | US20040253610 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 12/16/2004 | US20040253595 P53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator |
| 12/16/2004 | US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders |
| 12/16/2004 | US20040253587 Antagonists of interleukin-15 |
| 12/16/2004 | US20040253580 Nucleotide sequences coding viral protein for use in treatment and prevention of viral disease in fish; veterinary medicine |
| 12/16/2004 | US20040253250 Compositions and methods for regulating lymphocyte activation |
| 12/16/2004 | US20040253247 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 12/16/2004 | US20040253246 isolated nucleic acid (DNA, cDNA, or RNA); an expression vector; host cell expressing the vector; a polypeptide; detecting hematogenous micrometastic tumor cells; determining prostate cancer progression |
| 12/16/2004 | US20040253244 Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the same |
| 12/16/2004 | US20040253242 immunoglobulins or fragments comprising complementarity determining regions (CDR) having segments replaced with human brain natriuretic peptides, glucagon-like peptides, exendins, glucagons, pituitary adenylate cyclase-activating polypeptides and/or mimetics; immunotherapy |
| 12/16/2004 | US20040253241 Inducible ligand for alpha1beta1 integrin and uses |
| 12/16/2004 | US20040253240 immunogens used to induce immune response against specific epitopes of apolipoproteins; prophylaxis of atherosclerosis; immunotherapy |
| 12/16/2004 | US20040253238 Modified antibody |
| 12/16/2004 | US20040253237 Methods of treatment of ulcerative colitis with anti-CD3 antibodies |
| 12/16/2004 | US20040253236 Glycoprotein VI and uses thereof |
| 12/16/2004 | US20040253235 administering interferon-beta (IFN- beta) receptor agonist and tumor associated antigen to increase an immune response against the tumor cells |
| 12/16/2004 | US20040253234 DNA sequences that code antibodies or fragments; genetic vectors and host cells transformed by the vector, used for diagnosis and prophylaxis of cancer |
| 12/16/2004 | US20040253233 genetic engineered chimeric and humanized antibodies obtained from murine monoclonal antibody P3 (MAb P3) and its antiidiotypic antibodies, used as antitumor agents |
| 12/16/2004 | US20040253232 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 12/16/2004 | US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis |
| 12/16/2004 | US20040253230 Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1 |
| 12/16/2004 | US20040253229 administering a mixture of carriers and drugs that modulate signal transduction mediated by activation inducible lymphocyte immunomodulatory molecule (AILIM); immunosuppressants |
| 12/16/2004 | US20040253222 transgenic neisseria having mutant phospholipase gene so that the bacteria has reduced phospholipase D activity as compared wild-type; polypeptide and polynucleotide, used for immunization of mammals against bacterial infections |
| 12/16/2004 | CA2568806A1 Methods for detecting and treating cancer using podocalyxin and/or endoglycan |
| 12/16/2004 | CA2531569A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stemcell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transformation introducing the gene |
| 12/16/2004 | CA2528851A1 Extracellular aspergillus polypeptides |
| 12/16/2004 | CA2527728A1 Micropositioning cells for tissue engineering |
| 12/16/2004 | CA2527726A1 De-immunized anti-cd3 antibody |
| 12/16/2004 | CA2526669A1 Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders |
| 12/16/2004 | CA2526509A1 Connective tissue growth factor antibodies |
| 12/16/2004 | CA2525975A1 Humanized antibodies that recognize beta amyloid peptide |
| 12/16/2004 | CA2524329A1 Anti-hgf-r antibodies and their use |
| 12/15/2004 | EP1486566A1 Proteins capable of binding to female sex hormones and process for producing the same |
| 12/15/2004 | EP1486560A2 Specific antibodies and antibody fragments for TGFBETA1 |
| 12/15/2004 | EP1486508A1 Use of the AL-1 neurotrophic factor, a ligand for an EPH-related tyrosine kinase receptor, for the preparation of a medicament for modulating angiogenesis associated disease or condition |
| 12/15/2004 | EP1485718A2 Method for monitoring collagen type ii degradation in cartilage |
| 12/15/2004 | EP1485486A2 Optimizing glycan processing in plants |
| 12/15/2004 | EP1485481A2 Fluorescent protein from aequorea coerulescens and uses thereof |
| 12/15/2004 | EP1485480A2 Cd40 splice variants, method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof |
| 12/15/2004 | EP1485477A2 Novel type-1 cytokine receptor glm-r |
| 12/15/2004 | EP1485468A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 12/15/2004 | EP1485415A2 Neoplasm specific antibodies and uses thereof |
| 12/15/2004 | EP1485414A2 A multifunctional complex for targeting specific phagocytosis of a target agent |
| 12/15/2004 | EP1485412A1 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy |
| 12/15/2004 | EP1485410A1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases |
| 12/15/2004 | EP1485407A1 A mutated immunoglobulin-binding protein |
| 12/15/2004 | EP1485130A2 Reagents and treatment methods for autoimmune diseases |
| 12/15/2004 | EP1485129A2 Nanostructures containing pilin protein |
| 12/15/2004 | EP1485128A2 Nanostructures containing antibody assembly units |
| 12/15/2004 | EP1485127A2 Administration of agents for the treatment of inflammation |
| 12/15/2004 | EP1485126A2 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 12/15/2004 | EP1485122A2 Novel application of vaccination against tnf-alpha |
| 12/15/2004 | EP1485075A2 Mhc-peptide complex binding ligands |
| 12/15/2004 | EP1263779B1 Self antigen vaccines for treating b cell lymphomas and other cancers |
| 12/15/2004 | EP1259248B1 Methods for treating cancers expressing vascular endothelial growth factor d |
| 12/15/2004 | EP1121599B1 Detection and quantification of vancomycin in biological fluids |
| 12/15/2004 | EP1116029A4 Apoptosis marker antibodies and methods of use |
| 12/15/2004 | EP1073461B1 Viral chimeras comprised of caev and hiv-1 genetic elements |
| 12/15/2004 | EP0968290B1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 12/15/2004 | EP0956304B1 Dendritic cell-specific antibodies |
| 12/15/2004 | EP0932666B1 Map kinases: polypeptides, polynucleotides and uses thereof |
| 12/15/2004 | EP0863204B1 Human cyclin i and gene encoding the same |
| 12/15/2004 | CN1555415A Synthetic HCV envelope proteins and their use for vaccination |